Transfection of the DAAO gene and subsequent induction of cytotoxic oxidative stress by D-alanine in 9L cells

Oncology Reports

Volumn 20, Issue 2, 2008, Pages 341-346

  Li, Jun ^a   Shen, Yuechun ^a   Liu, Anzhong ^a   Wang, Xiaoming ^a   Zhao, Chaochen ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

D alanine; D amino acid oxidase; Gene therapy; Tumor

Indexed keywords

COMPLEMENTARY DNA; DEXTRO ALANINE; DEXTRO AMINO ACID OXIDASE; DNA FRAGMENT; GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; GENE DIRECTED ENZYME PRODRUG THERAPY; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SUPERNATANT; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS TITRATION;

ALANINE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; D-AMINO-ACID OXIDASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE THERAPY; GENETIC VECTORS; GLIOMA; OXIDATIVE STRESS; PLASMIDS; RATS; RETROVIRIDAE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 48749131250     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000012     Document Type: Article

References (19)

1. Portsmouth D, Hlavaty J and Renner M: Suicide genes for cancer therapy. Mol Aspects Med 28: 4-41, 2007.
2. Schepelmann S and Springer CJ: Viral vectors for gene-directed enzyme prodrug therapy. Curr Gene Ther 6: 647-670, 2006.
3. Tishkov VI and Khoronenkova SV: D-amino acid oxidase: structure, catalytic mechanism, and practical application. Biochemistry 70: 40-54, 2005.
4. Pilone MS: D-amino acid oxidase: new findings. Cell Mol Life Sci 57: 1732-1747, 2000.
5. Stegman LD, Zheng H, Neal ER, et al: Induction of cytotoxic oxidative stress by D-alanine in brain tumor cells expressing Rhodotorula gracilis D-amino acid oxidase: a cancer gene therapy strategy. Hum Gene Ther 9:185-193, 1998.
6. Sasamura T, Matsuda A and Kokuba Y: Determination of D-amino acid oxidase activity in tumour cells. Ann Clin Biochem 39: 595-598, 2002.
7. Annegers JF, Schoenberg BS, Okazaki H and Kurland LT: Epidemiologic study of primary intracranial neoplasms. Arch Neurol 38: 217-219, 1981.
8. Staneczek W and Janisch W: Epidemiology of primary tumors of the central nervous system in children and adolescents. A population-based study. Pathologe 15: 207-215, 1994.
9. DeAngelis LM: Brain tumors. N Engl J Med 344: 114-123, 2001.
10. Davis FG, Kupelian V, Freels S, McCarthy B and Surawicz T: Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neurooncology 3: 152-158, 2001.
11. van Dillen IJ, Mulder NH, Vaalburg W, de Vries EF and Hospers GA: Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr Gene Ther 2: 307-322, 2002.
12. Robe PA, Jolois O, N'Guyen M, et al: Modulation of the HSV-TK/ ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication. Int J Oncol 25: 187-192, 2004.
13. Bourbeau D, Lavoie G, Nalbantoglu J and Massie B: Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status. J Gene Med 6: 1320-1332, 2004.
14. Trask TW, Trask RP, Guilar-Cordova E, et al: Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther 1: 195-203, 2000.
15. Floeth FW, Shand N, Bojar H, et al: Local inflammation and devascularization-in vivo mechanisms of the 'bystander effect' in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma. Cancer Gene Ther 8: 843-851, 2001.
16. Kaliberov SA, Market JM, Gillespie GY, et al: Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma. Gene Ther 14: 1111-1119, 2007.
17. Vidair CA and Dewey WC: Division-associated and division-independent hyperthermic cell death: comparison with other cytotoxic agents. Int J Hyperthermia 7: 51-60, 1991.
18. Liu X, He G, Wang X, et al: Association of DAAO with schizophrenia in the Chinese population. Neurosci Lett 369: 228-233, 2004.
19. Boks MP, Rietkerk T, van de Beek MH, Sommer IE, de Koning TJ and Kahn RS: Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol 17: 567-572, 2007.